Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_assertion description "[The trifunctional carbamoylphosphate synthetase/aspartate transcarbamyltransferase/dihydroorotase (CAD) gene is hormone responsive in MCF-7 and ZR-75 breast cancer cells, and this response is inhibited by the aryl hydrocarbon receptor (AhR) agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_assertion evidence source_evidence_literature NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_assertion SIO_000772 16675542 NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_assertion wasDerivedFrom befree-2016 NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_assertion wasGeneratedBy ECO_0000203 NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.
- befree-2016 importedOn "2016-02-19" NP548220.RA6yu4sHy0R_3kZ5Ny-mItWEKyAcxEuaOVTvEsqF-h2h4130_provenance.